社论:食品中的乳化剂和增稠剂--它们会改变肠道渗透性吗?作者回复

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-09-09 DOI:10.1111/apt.18266
Jessica A. Fitzpatrick, Peter R. Gibson, Emma P. Halmos
{"title":"社论:食品中的乳化剂和增稠剂--它们会改变肠道渗透性吗?作者回复","authors":"Jessica A. Fitzpatrick,&nbsp;Peter R. Gibson,&nbsp;Emma P. Halmos","doi":"10.1111/apt.18266","DOIUrl":null,"url":null,"abstract":"<p>The relationship between dietary emulsifiers and Crohn's disease is intriguing and warrants continuing exploration. It may present information not only on pathogenesis and preventive strategies,<span><sup>1</sup></span> but also on dietary advice to control inflammation in patients with established Crohn's disease.<span><sup>2</sup></span> The emulsifier story has excited many. The European Society for Clinical Nutrition and the International Organisation for the Study of IBD have concerningly translated preclinical data to ‘evidence-based’ clinical advice for patients with Crohn's disease to avoid foods with added emulsifiers.<span><sup>3, 4</sup></span> This dietary advice is not simple to implement for people living with Crohn's disease, since there are over 40 different emulsifiers in our food supply identified on ingredients lists on packaged food as either additive numbers or in expanded form. Over-restriction of many packaged foods will have considerable effects on food-related quality of life and psychosocial interactions, and is impractical in our modern world.</p><p>The editorial from Reid and Spiller<span><sup>5</sup></span> on our study regarding the effects of diets varying in emulsifier content on intestinal barrier function<span><sup>6</sup></span> has highlighted the gulf between the preclinical IBD models and how to establish the type of evidence that can be validly translated to dietary recommendations. Reid and Spiller recommend a scientist's reductionist approach to study single emulsifiers to determine their biological effects. We have taken the clinically translatable dietetic approach to studying emulsifiers as a group in the existing food supply. Both approaches are required for progressing our understanding of emulsifiers impacting Crohn's disease, but there are advantages to the dietetic approach. First, the emulsifiers examined represent what is actually in our food supply as opposed to choosing what Reid and Spiller correctly described as ‘obscure’ emulsifiers. Second, the doses to which research subjects are to be exposed in a high-emulsifier diet are those of the ‘real world’,<span><sup>7</sup></span> as opposed to the large, pharmacological doses of specific emulsifiers that have been administered to mice and humans in studies to date.<span><sup>8-10</sup></span> Translating the effects of megadoses to those that might be reasonably consumed in a high-emulsifier diet is flawed and dangerous. More care in dosing has to be taken if the results are to be meaningfully applied to dietary management. Third, the concept that individual emulsifiers will work similarly when not incorporated in food and not interact with other emulsifiers is oversimplified and untested. Fourth, as Reid and Spiller commented, the heterogeneity in emulsifier action in the gut is important to consider, with some thickeners potentially having a beneficial effect.</p><p>Studying intake of emulsifiers as they are found in the food supply enables information on their biological effect as a whole to be examined, and the effect of their minimisation in the diet determined. However, both research approaches are needed to identify the offending culprit(s) or the emulsifier(s) with benefit. To avoid demonisation of food components without evidence, suggestions of causal links from preclinical studies need to be evaluated in carefully designed diet-controlled human trials, and then, much awaited evaluation in patients with Crohn's disease. For now, do not feel guilty if you eat ice-cream!</p><p><b>Jessica A. Fitzpatrick:</b> Writing – review and editing; conceptualization. <b>Peter R. Gibson:</b> Writing – review and editing; conceptualization. <b>Emma P. Halmos:</b> Writing – review and editing; conceptualization.</p><p>There was no funding support for this manuscript.</p><p>This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18222</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":null,"pages":null},"PeriodicalIF":6.6000,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18266","citationCount":"0","resultStr":"{\"title\":\"Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply\",\"authors\":\"Jessica A. Fitzpatrick,&nbsp;Peter R. Gibson,&nbsp;Emma P. Halmos\",\"doi\":\"10.1111/apt.18266\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The relationship between dietary emulsifiers and Crohn's disease is intriguing and warrants continuing exploration. It may present information not only on pathogenesis and preventive strategies,<span><sup>1</sup></span> but also on dietary advice to control inflammation in patients with established Crohn's disease.<span><sup>2</sup></span> The emulsifier story has excited many. The European Society for Clinical Nutrition and the International Organisation for the Study of IBD have concerningly translated preclinical data to ‘evidence-based’ clinical advice for patients with Crohn's disease to avoid foods with added emulsifiers.<span><sup>3, 4</sup></span> This dietary advice is not simple to implement for people living with Crohn's disease, since there are over 40 different emulsifiers in our food supply identified on ingredients lists on packaged food as either additive numbers or in expanded form. Over-restriction of many packaged foods will have considerable effects on food-related quality of life and psychosocial interactions, and is impractical in our modern world.</p><p>The editorial from Reid and Spiller<span><sup>5</sup></span> on our study regarding the effects of diets varying in emulsifier content on intestinal barrier function<span><sup>6</sup></span> has highlighted the gulf between the preclinical IBD models and how to establish the type of evidence that can be validly translated to dietary recommendations. Reid and Spiller recommend a scientist's reductionist approach to study single emulsifiers to determine their biological effects. We have taken the clinically translatable dietetic approach to studying emulsifiers as a group in the existing food supply. Both approaches are required for progressing our understanding of emulsifiers impacting Crohn's disease, but there are advantages to the dietetic approach. First, the emulsifiers examined represent what is actually in our food supply as opposed to choosing what Reid and Spiller correctly described as ‘obscure’ emulsifiers. Second, the doses to which research subjects are to be exposed in a high-emulsifier diet are those of the ‘real world’,<span><sup>7</sup></span> as opposed to the large, pharmacological doses of specific emulsifiers that have been administered to mice and humans in studies to date.<span><sup>8-10</sup></span> Translating the effects of megadoses to those that might be reasonably consumed in a high-emulsifier diet is flawed and dangerous. More care in dosing has to be taken if the results are to be meaningfully applied to dietary management. Third, the concept that individual emulsifiers will work similarly when not incorporated in food and not interact with other emulsifiers is oversimplified and untested. Fourth, as Reid and Spiller commented, the heterogeneity in emulsifier action in the gut is important to consider, with some thickeners potentially having a beneficial effect.</p><p>Studying intake of emulsifiers as they are found in the food supply enables information on their biological effect as a whole to be examined, and the effect of their minimisation in the diet determined. However, both research approaches are needed to identify the offending culprit(s) or the emulsifier(s) with benefit. To avoid demonisation of food components without evidence, suggestions of causal links from preclinical studies need to be evaluated in carefully designed diet-controlled human trials, and then, much awaited evaluation in patients with Crohn's disease. For now, do not feel guilty if you eat ice-cream!</p><p><b>Jessica A. Fitzpatrick:</b> Writing – review and editing; conceptualization. <b>Peter R. Gibson:</b> Writing – review and editing; conceptualization. <b>Emma P. Halmos:</b> Writing – review and editing; conceptualization.</p><p>There was no funding support for this manuscript.</p><p>This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18222</p>\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2024-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18266\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/apt.18266\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18266","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

膳食乳化剂与克罗恩病之间的关系令人好奇,值得继续探索。它不仅可以提供有关发病机理和预防策略的信息1 ,还可以提供有关已确诊克罗恩病患者控制炎症的饮食建议2。欧洲临床营养学会(European Society for Clinical Nutrition)和国际肠道疾病研究组织(International Organisation for the Study of IBD)将临床前数据转化为 "循证 "临床建议,要求克罗恩病患者避免食用添加乳化剂的食品,这令人担忧。Reid 和 Spiller5 就我们关于乳化剂含量不同的膳食对肠屏障功能影响的研究发表的社论6 强调了临床前 IBD 模型与如何建立可有效转化为膳食建议的证据类型之间的鸿沟。Reid 和 Spiller 建议科学家采用还原法研究单一乳化剂,以确定其生物效应。我们采用了可临床转化的营养学方法,将乳化剂作为现有食品供应中的一组乳化剂进行研究。这两种方法对于加深我们对影响克罗恩病的乳化剂的了解都是必要的,但营养学方法有其优势。首先,所研究的乳化剂代表了食品供应中的实际情况,而不是选择里德和斯皮勒正确描述的 "模糊 "乳化剂。其次,研究对象在高乳化剂膳食中接触的剂量是 "真实世界 "7 中的剂量,而不是迄今为止在研究中对小鼠和人类施用的大剂量、药理学剂量的特定乳化剂。如果要将研究结果有意义地应用于膳食管理,就必须在剂量上更加谨慎。第三,认为单个乳化剂在未加入食物中时也会发挥类似作用,并且不会与其他乳化剂发生相互作用的概念过于简单,也未经检验。第四,正如里德和斯皮勒所评论的,乳化剂在肠道中的作用具有异质性,有些增稠剂可能会产生有益的影响,这一点必须加以考虑。研究食品供应中乳化剂的摄入量,可以从整体上研究乳化剂的生物效应,并确定在膳食中尽量减少乳化剂的影响。不过,这两种研究方法都需要,以确定违规的罪魁祸首或有益的乳化剂。为了避免在没有证据的情况下将食物成分妖魔化,需要在精心设计的饮食控制人体试验中评估临床前研究提出的因果关系,然后在克罗恩病患者身上进行期待已久的评估。现在,如果你吃了冰淇淋,请不要感到内疚!杰西卡-A-菲茨帕特里克(Jessica A. Fitzpatrick):写作--审阅和编辑;构思。彼得-R-吉布森:写作--审阅和编辑;构思。Emma P. Halmos:本文与菲茨帕特里克等人的论文链接。要查看这些文章,请访问 https://doi.org/10.1111/apt.18172 和 https://doi.org/10.1111/apt.18222。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply

The relationship between dietary emulsifiers and Crohn's disease is intriguing and warrants continuing exploration. It may present information not only on pathogenesis and preventive strategies,1 but also on dietary advice to control inflammation in patients with established Crohn's disease.2 The emulsifier story has excited many. The European Society for Clinical Nutrition and the International Organisation for the Study of IBD have concerningly translated preclinical data to ‘evidence-based’ clinical advice for patients with Crohn's disease to avoid foods with added emulsifiers.3, 4 This dietary advice is not simple to implement for people living with Crohn's disease, since there are over 40 different emulsifiers in our food supply identified on ingredients lists on packaged food as either additive numbers or in expanded form. Over-restriction of many packaged foods will have considerable effects on food-related quality of life and psychosocial interactions, and is impractical in our modern world.

The editorial from Reid and Spiller5 on our study regarding the effects of diets varying in emulsifier content on intestinal barrier function6 has highlighted the gulf between the preclinical IBD models and how to establish the type of evidence that can be validly translated to dietary recommendations. Reid and Spiller recommend a scientist's reductionist approach to study single emulsifiers to determine their biological effects. We have taken the clinically translatable dietetic approach to studying emulsifiers as a group in the existing food supply. Both approaches are required for progressing our understanding of emulsifiers impacting Crohn's disease, but there are advantages to the dietetic approach. First, the emulsifiers examined represent what is actually in our food supply as opposed to choosing what Reid and Spiller correctly described as ‘obscure’ emulsifiers. Second, the doses to which research subjects are to be exposed in a high-emulsifier diet are those of the ‘real world’,7 as opposed to the large, pharmacological doses of specific emulsifiers that have been administered to mice and humans in studies to date.8-10 Translating the effects of megadoses to those that might be reasonably consumed in a high-emulsifier diet is flawed and dangerous. More care in dosing has to be taken if the results are to be meaningfully applied to dietary management. Third, the concept that individual emulsifiers will work similarly when not incorporated in food and not interact with other emulsifiers is oversimplified and untested. Fourth, as Reid and Spiller commented, the heterogeneity in emulsifier action in the gut is important to consider, with some thickeners potentially having a beneficial effect.

Studying intake of emulsifiers as they are found in the food supply enables information on their biological effect as a whole to be examined, and the effect of their minimisation in the diet determined. However, both research approaches are needed to identify the offending culprit(s) or the emulsifier(s) with benefit. To avoid demonisation of food components without evidence, suggestions of causal links from preclinical studies need to be evaluated in carefully designed diet-controlled human trials, and then, much awaited evaluation in patients with Crohn's disease. For now, do not feel guilty if you eat ice-cream!

Jessica A. Fitzpatrick: Writing – review and editing; conceptualization. Peter R. Gibson: Writing – review and editing; conceptualization. Emma P. Halmos: Writing – review and editing; conceptualization.

There was no funding support for this manuscript.

This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18222

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Editorial: The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors. Authors' Reply Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study Editorial: Enhancing targeted screening of people living with HIV for liver fibrosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1